Literature DB >> 15494602

Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?

Stephen H Taplin1, Laura Ichikawa, Marianne Ulcickas Yood, M Michele Manos, Ann M Geiger, Sheila Weinmann, Joyce Gilbert, Judy Mouchawar, Wendy A Leyden, Robin Altaras, Robert K Beverly, Deborah Casso, Emily Oakes Westbrook, Kimberly Bischoff, Jane G Zapka, William E Barlow.   

Abstract

BACKGROUND: Mammography screening increases the detection of early-stage breast cancers. Therefore, implementing screening should reduce the percentage of women who are diagnosed with late-stage disease. However, despite high national mammography screening rates, late-stage breast cancers still occur, possibly because of failures in screening implementation.
METHODS: Using data from seven health care plans that included 1.5 million women aged 50 years or older, we conducted retrospective reviews of chart and automated data for 3 years before 1995-1999 diagnoses of late-stage (metastatic and/or tumor size > or =3 cm; case subjects, n = 1347) and early-stage breast cancers (control subjects, n = 1347). We categorized the earliest screening mammogram during the period 13-36 months before diagnosis as none (absence of screening), negative (absence of detection), or positive (potential breakdown in follow-up). We compared the proportion of case and control subjects in each category of screening implementation and estimated the likelihood (odds ratio [OR] with 95% confidence intervals [CIs]) of late-stage breast cancer. We also evaluated demographic characteristics associated with absence of screening in women with late-stage disease. All statistical tests were two-sided.
RESULTS: Absence of screening, absence of detection, and potential breakdown in follow-up were distributed differently among case (52.1%, 39.5%, and 8.4%, respectively) and control subjects (34.4%, 56.9%, and 8.8%, respectively) (P = .03). Among all women, the odds of having late-stage cancer were higher among women with an absence of screening (OR = 2.17, 95% CI = 1.84 to 2.56; P<.001). Among case patients, women were more likely to be in the absence-of-screening group if they were aged 75 years or older (OR = 2.77, 95% CI = 2.10 to 3.65), unmarried (OR = 1.78, 95% CI = 1.41 to 2.24), or without a family history of breast cancer (OR = 1.84, 95% CI = 1.45 to 2.34). A higher proportion of women from census blocks with less education (58.5% versus 49.4%; P = .003) or lower median annual income (54.4% versus 42.9%; P = .004) were in the absence-of-screening category compared with the proportion for the other two categories combined.
CONCLUSIONS: To reduce late-stage breast cancer occurrence, reaching unscreened women, including elderly, unmarried, low-income, and less educated women, should be made a top priority for screening implementation.

Entities:  

Mesh:

Year:  2004        PMID: 15494602     DOI: 10.1093/jnci/djh284

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  60 in total

1.  Disparities in routine breast cancer screening for Medicaid managed care members with a work-limiting disability.

Authors:  Sharada Weir; Heather E Posner; Jianying Zhang; Whitney C Jones; Georgianna Willis; Jeffrey D Baxter; Robin E Clark
Journal:  Medicare Medicaid Res Rev       Date:  2011-11-04

Review 2.  Toward improving the quality of cancer care: addressing the interfaces of primary and oncology-related subspecialty care.

Authors:  Stephen Hunt Taplin; Anne Brown Rodgers
Journal:  J Natl Cancer Inst Monogr       Date:  2010

3.  Teams and teamwork during a cancer diagnosis: interdependency within and between teams.

Authors:  Stephen H Taplin; Sallie Weaver; Veronica Chollette; Lawrence B Marks; Andrew Jacobs; Gordon Schiff; Carrie T Stricker; Suanna S Bruinooge; Eduardo Salas
Journal:  J Oncol Pract       Date:  2015-04-14       Impact factor: 3.840

4.  Mediating factors in the relationship between income and mammography use in low-income insured women.

Authors:  Alice N Park; Diana S M Buist; Jasmin A Tiro; Stephen H Taplin
Journal:  J Womens Health (Larchmt)       Date:  2008-10       Impact factor: 2.681

5.  Achieving Coordinated Care for Patients With Complex Cases of Cancer: A Multiteam System Approach.

Authors:  Simon J Craddock Lee; Mark A Clark; John V Cox; Burton M Needles; Carole Seigel; Bijal A Balasubramanian
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

6.  Time to diagnosis and breast cancer stage by race/ethnicity.

Authors:  Erica T Warner; Rulla M Tamimi; Melissa E Hughes; Rebecca A Ottesen; Yu-Ning Wong; Stephen B Edge; Richard L Theriault; Douglas W Blayney; Joyce C Niland; Eric P Winer; Jane C Weeks; Ann H Partridge
Journal:  Breast Cancer Res Treat       Date:  2012-10-26       Impact factor: 4.872

7.  Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.

Authors:  Aruna Kamineni; Melissa L Anderson; Emily White; Stephen H Taplin; Peggy Porter; Rachel Ballard-Barbash; Kathleen Malone; Diana S M Buist
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

8.  Public health national approach to reducing breast and cervical cancer disparities.

Authors:  Jacqueline W Miller; Marcus Plescia; Donatus U Ekwueme
Journal:  Cancer       Date:  2014-08-15       Impact factor: 6.860

Review 9.  Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice.

Authors:  Amit G Singal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2015-08-15       Impact factor: 11.382

10.  Religiosity, spirituality, and cancer fatalism beliefs on delay in breast cancer diagnosis in African American women.

Authors:  Mary Magee Gullatte; Otis Brawley; Anita Kinney; Barbara Powe; Kathi Mooney
Journal:  J Relig Health       Date:  2009-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.